Medicare Part D and Medicare Advantage plans with prescription drug coverage may cover Xarelto if it appears on the plan’s formulary. There are currently no generic alternatives available for Xarelto, ...

A new oral suspension formulation of Xarelto has also been approved by the FDA. The Food and Drug Administration (FDA) has approved Xarelto ® (rivaroxaban) for 2 new pediatric indications: treatment ...

Please provide your email address to receive an email when new articles are posted on . Xarelto was superior to aspirin for lowering the risk for recurrent stroke or systemic embolism among ...

(Reuters) -Older adults taking Bayer AG's blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious bleeding and stroke compared to ...

Eliquis and Xarelto, two blood-thinning medications that are already among Medicare's costliest, have seen their list prices more than double since entering the market, finds a new report by Patients ...

Lupin has received the Food and Drug Administration’s green light for rivaroxaban tablets, in 10 mg, 15 mg and 20 mg, which is the generic of Janssen’s Xarelto. This product will be manufactured at ...

Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Bayer AG, in collaboration with Janssen Research & Development, LLC, has ...

Rivaroxaban for oral suspension, 1 mg/ml (RLD Xarelto) had a market value of roughly $11 million, per IQVIA July 2025 data. Lupin has received approval from the Food and Drug Administration for ...

Johnson & Johnson and Bayer’s wide-spanning VOYAGER PAD study continues to be a gold mine for proving its Xarelto’s worth in several subsets of patients with peripheral artery disease (PAD). New ...

After a tough showing earlier this year, Bayer has logged another Xarelto downturn in the second quarter. The aging blood thinner continues to feel the squeeze from an aggressive drug discounting ...